Abiopharma

🔍 KATHWARI M FAROOQ (Director)

Company: ETHAN ALLEN INTERIORS INC (ETD)

Report Date: 2026-09-02

Detailed Transactions and Holdings:

• Sold 22,811 shares of Common Stock at $25.04 per share (Direct)
  Date: 2026-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,465,530.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 266 shares of Common Stock at $25.04 per share (Direct)
  Date: 2026-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 22,081.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 266 shares of Common Stock at $25.04 per share (Direct)
  Date: 2026-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 22,081.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 265 shares of Common Stock at $25.04 per share (Direct)
  Date: 2026-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 22,077.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 266 shares of Common Stock at $25.04 per share (Direct)
  Date: 2026-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 22,081.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-09-02 | Code: H | nature_of_ownership: Shares held by spouse | shares_owned_after: 15,364.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-09-02 | Code: H | nature_of_ownership: Shares held in 401(k) plan | shares_owned_after: 8,549.00

Footnotes:

• F1: This transaction was pursuant to a Rule 10b5-1 stock selling plan adopted on June 10, 2025 by M. Farooq Kathwari, with an effective date of September 15, 2025. This trading plan was previously disclosed in the Issuer's Annual Report on Form 10-K filed on August 22, 2025. In addition, on September 2, 2026, 16,726 shares of Ethan Allen common stock were sold by the Irfan Kathwari Foundation (all of whose shares Mr. Kathwari is deemed to beneficially own, but over which he has no reportable pecuniary interest) pursuant to the above-referenced Rule 10b5-1 stock selling plan.